We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$237M
AUM Growth
-$12.4M
Cap. Flow
+$233M
Cap. Flow %
98.55%
Top 10 Hldgs %
40.76%
Holding
84
New
83
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 30.64%
2 Financials 21.74%
3 Real Estate 18.13%
4 Industrials 6.76%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCAC.U
26
DELISTED
Hennessy Capital Acquisition Corp. III Units, each consisting of one share of Common Stock and one-h
HCAC.U
$3.02M 1.28%
+300,000
New +$3.02M
BY icon
27
Byline Bancorp
BY
$1.78B
$3.01M 1.27%
+150,000
New +$3.01M
NTB icon
28
Bank of N.T. Butterfield & Son
NTB
$2.43B
$2.85M 1.2%
+83,614
New +$2.79M
GMS
29
DELISTED
GMS Inc
GMS
$2.81M 1.19%
+100,000
New +$3.36M
MB
30
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$2.72M 1.15%
+100,000
New +$2.75M
TMHC
31
DELISTED
Taylor Morrison
TMHC
$2.4M 1.01%
+100,000
New +$2.3M
DOVA
32
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$2.23M 0.94%
+100,000
New +$2.1M
CWH icon
33
Camping World
CWH
$639M
$2M 0.85%
+65,000
New +$1.92M
ORGO icon
34
Organogenesis Holdings
ORGO
$305M
$1.97M 0.83%
+200,000
New +$1.97M
REVG
35
DELISTED
REV Group
REVG
$1.91M 0.81%
+68,854
New +$1.92M
ADC icon
36
Agree Realty
ADC
$9.34B
$1.83M 0.78%
+40,000
New +$1.9M
AKBA icon
37
Akebia Therapeutics
AKBA
$354M
$1.8M 0.76%
+125,000
New +$1.58M
NERV icon
38
Minerva Neurosciences
NERV
$185M
$1.77M 0.75%
+25,000
New +$1.62M
LCAHW
39
DELISTED
Landcadia Holdings, Inc. Warrant
LCAHW
$1.72M 0.73%
+200,000
New +$151K
FR icon
40
First Industrial Realty Trust
FR
$8.73B
$1.6M 0.68%
+55,900
New +$1.59M
MRSN
41
DELISTED
Mersana Therapeutics
MRSN
$1.51M 0.64%
+4,311
New +$1.49M
GNMK
42
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.48M 0.63%
+125,000
New +$1.6M
TNTR
43
DELISTED
Tintri, Inc. Common Stock
TNTR
$1.45M 0.61%
+200,000
New +$1.45M
JCAP
44
DELISTED
Jernigan Capital, Inc.
JCAP
$1.43M 0.6%
+65,000
New +$1.48M
HESM icon
45
Hess Midstream
HESM
$5.24B
$1.4M 0.59%
+68,941
New +$1.65M
TSRO
46
DELISTED
TESARO, Inc.
TSRO
$1.4M 0.59%
+10,000
New +$1.45M
ARGX icon
47
argenx
ARGX
$53.4B
$1.38M 0.58%
+65,000
New +$1.35M
FSTX
48
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.35M 0.57%
+25,000
New +$1.16M
PK icon
49
Park Hotels & Resorts
PK
$3.03B
$1.35M 0.57%
+50,000
New +$1.32M
ARR
50
Armour Residential REIT
ARR
$2.33B
$1.25M 0.53%
+10,000
New +$1.26M

Similar funds

Monashee Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Monashee Investment Management held 84 positions worth $237M, down 5% from $249M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Monashee Investment Management deployed $233M of net new capital in Q2 2017, opening 83 new positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 300,000 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 19% a quarter earlier, followed by Financials and Real Estate.

  • Monashee Investment Management's largest Q2 2017 buy was Athene Holding Ltd. Class A Common Shares: 300,000 shares worth $14.9M.
  • Monashee Investment Management's ten largest holdings make up 41% of its $237M portfolio in Q2 2017.
  • Monashee Investment Management opened 83 new positions and closed 0 in Q2 2017.
  • Monashee Investment Management's portfolio value fell 5% quarter-over-quarter to $237M.

Based on Monashee Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.